rs201808974
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_015272.5(RPGRIP1L):c.883-32_883-30delAAT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00634 in 1,594,690 control chromosomes in the GnomAD database, including 79 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0071 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0063 ( 68 hom. )
Consequence
RPGRIP1L
NM_015272.5 intron
NM_015272.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.612
Genes affected
RPGRIP1L (HGNC:29168): (RPGRIP1 like) The protein encoded by this gene can localize to the basal body-centrosome complex or to primary cilia and centrosomes in ciliated cells. The encoded protein has been found to interact with nephrocystin-4. Defects in this gene are a cause of Joubert syndrome type 7 (JBTS7) and Meckel syndrome type 5 (MKS5). [provided by RefSeq, Jun 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 16-53673045-CATT-C is Benign according to our data. Variant chr16-53673045-CATT-C is described in ClinVar as [Likely_benign]. Clinvar id is 260612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00714 (1087/152246) while in subpopulation NFE AF = 0.00768 (522/67996). AF 95% confidence interval is 0.00713. There are 11 homozygotes in GnomAd4. There are 621 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00716 AC: 1089AN: 152128Hom.: 11 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1089
AN:
152128
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00783 AC: 1871AN: 238842 AF XY: 0.00817 show subpopulations
GnomAD2 exomes
AF:
AC:
1871
AN:
238842
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00625 AC: 9022AN: 1442444Hom.: 68 AF XY: 0.00648 AC XY: 4650AN XY: 718122 show subpopulations
GnomAD4 exome
AF:
AC:
9022
AN:
1442444
Hom.:
AF XY:
AC XY:
4650
AN XY:
718122
Gnomad4 AFR exome
AF:
AC:
20
AN:
33136
Gnomad4 AMR exome
AF:
AC:
169
AN:
44096
Gnomad4 ASJ exome
AF:
AC:
397
AN:
25868
Gnomad4 EAS exome
AF:
AC:
0
AN:
39456
Gnomad4 SAS exome
AF:
AC:
313
AN:
85264
Gnomad4 FIN exome
AF:
AC:
1589
AN:
51486
Gnomad4 NFE exome
AF:
AC:
6137
AN:
1098524
Gnomad4 Remaining exome
AF:
AC:
375
AN:
59608
Heterozygous variant carriers
0
422
845
1267
1690
2112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00714 AC: 1087AN: 152246Hom.: 11 Cov.: 32 AF XY: 0.00834 AC XY: 621AN XY: 74440 show subpopulations
GnomAD4 genome
AF:
AC:
1087
AN:
152246
Hom.:
Cov.:
32
AF XY:
AC XY:
621
AN XY:
74440
Gnomad4 AFR
AF:
AC:
0.000794071
AN:
0.000794071
Gnomad4 AMR
AF:
AC:
0.0058208
AN:
0.0058208
Gnomad4 ASJ
AF:
AC:
0.0129758
AN:
0.0129758
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.00269151
AN:
0.00269151
Gnomad4 FIN
AF:
AC:
0.0336665
AN:
0.0336665
Gnomad4 NFE
AF:
AC:
0.00767692
AN:
0.00767692
Gnomad4 OTH
AF:
AC:
0.0109005
AN:
0.0109005
Heterozygous variant carriers
0
57
114
172
229
286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3474
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
May 28, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at